Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heavenly Rx is a private cannabinoid wellness holding company formed to acquire and operate brands and assets in the hemp-derived CBD and THC-free cannabinoid market. The company has described a vertically integrated "seed to shelf" strategy spanning hemp cultivation, extraction, processing, manufacturing, brand development, and retail distribution. Its portfolio activity has included hemp processing and extraction through Blühen Botanicals and consumer CBD brands such as PureKana, with stated ambitions across topicals, tinctures, ingestibles, beauty, bath and body, pet products, and beverages. Heavenly Rx appears to operate more like a branded wellness and consumer health platform than a drug-development biotech, with commercial rather than clinical-stage products. Leadership has included consumer packaged goods veterans, notably Paul Norman, reflecting the company's CPG-oriented growth strategy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heavenly Rx.